Department of Commerce
Foreign-Trade Zones Board
- [B-19-2022]
On May 13, 2022, AbbVie Ltd., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 7I, in Barceloneta, Puerto Rico.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (87 FR 30448, May 19, 2022). On September 12, 2022, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to ( printed page 56928) the FTZ Act and the FTZ Board's regulations, including section 400.14.
Dated: September 12, 2022.
Christopher Kemp,
Acting Executive Secretary.